Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of OsrhCT in Patients With Pleurisy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety, tolerability, and preliminary efficacy of OsrhCT in pleurisy; the study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pleurisy

Drugs mentioned

• OsrhCT

Snippet

Sponsor: Healthgen Biotechnology Corp. | Conditions: Pleurisy | Phase 1 | Status: NOT_YET_RECRUITING